Compounds for PIM kinase inhibition and for treating malignancy

Details for Australian Patent Application No. 2010318312 (hide)

Owner Sygnis Bioscience GmbH & Co. KG

Inventors Schneider, Armin; Dittgen, Tanjew

Agent Pizzeys

Pub. Number AU-A-2010318312

PCT Pub. Number WO2011/057784

Priority 09014103.7 11.11.09 EP

Filing date 11 November 2010

Wipo publication date 19 May 2011

International Classifications

C07D 217/02 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 217/22 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

Event Publications

3 May 2012 PCT application entered the National Phase

  PCT publication WO2011/057784 Priority application(s): WO2011/057784

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010318316-Antibodies specific for Claudin 6 (CLDN6)

2010318304-Method for producing triangular packaging bags and assembly therefor